Synergistic effect of combination chemotherapy with praziquantel and DW-3-15 for Schistosoma japonicum in vitro and in vivo.

Abstract

BACKGROUND:

Schistosomiasis is a debilitating and neglected tropical disease for which praziquantel (PZQ) remains the first-choice drug for treatment and control of the disease. In our previous studies, we found that the patented compound DW-3-15 (patent no. ZL201110142538.2) displayed significant and stabilized antiparasitic activity through a mechanism that might be distinct from PZQ. Here, we investigated the antischistosomal efficacy of PZQ combined with DW-3-15 against schistosomula and adult worms of Schistosoma japonicum in vitro and in vivo, to verify whether there was a synergistic effect of the two compounds.

METHODS:

The antischistosomal efficacy of PZQ combined with DW-3-15 in comparison with an untreated control and monotherapy group against schistosomula and adult worms was assessed both in vitro and in vivo. Parasitological studies, scanning electron microscopy, combination index, and histopathological analysis were used for the assessment.

RESULTS:

The results showed significantly reduced viability of schistosomes, achieving 100% viability reduction for juveniles and males by combination chemotherapy using PZQ together with DW-3-15 in vitro. The combination index was 0.28, 0.27, and 0.53 at the higher concentration of PZQ combined with DW-3-15 against juveniles, males, and females, respectively, indicating that the two compounds display strong synergism. Scanning electron microscopy observations also demonstrated that the compound combination induced more severe and extensive alterations to the tegument and subtegument of S. japonicum than those with each compound alone. In vivo, compared with the single-compound-treated group, the group treated with the higher-dose combination demonstrated the best schistosomicidal efficacy, with significantly reduced worm burden, egg burden, and granuloma count and area, which was evident against schistosomula and adult worms.

CONCLUSIONS:

Our study provides a potential novel chemotherapy for schistosomiasis caused by S. japonicum. It would improve the antischistosomal effect on schistosomula and adult worms of S. japonicum, and decrease individual dosages.

• Authors: Zi-Yin Yang, Zi-Hao Liu, Ya-Nan Zhang, Chen Li, Lei Liu, Wen-Jie Pu, Shi-Qi Xie, Jing Xu, Chao-Ming Xia
• Journal: Parasites & vectors (Parasit Vectors) Vol. 14 Issue 1 Pg. 550 (Oct 26 2021) ISSN: 1756-3305 [Electronic] England
• PMID: 34702326 (Publication Type: Journal Article)
• Copyright: © 2021. The Author(s).

Chemical References

• Schistosomicides
• Praziquantel

Topics

• Animals
• Drug Synergism
• Drug Therapy, Combination (methods)
• Female
• Mice, Inbred ICR
• Parasite Egg Count
• Praziquantel (pharmacology, therapeutic use)
• Schistosoma japonicum (drug effects)
• Schistosomicides (pharmacology, therapeutic use)